Patrick W Smith
Insider (Form 4 reporting owner): 10% owner CIK 1167028Name as filed: SMITH PATRICK WIts filings on EDGARAll insiders
Measures activity, not value. Not investment advice.
Since 16 May 2018, sold $786.5M in 49 sales (22 under a 10b5-1 plan set in advance) and bought $2.4M in 5 open-market purchases across 2 companies.
Companies
Role on the latest Form 4 for each; open-market trades counted| Company | Role | Trades from | to | Purchases | Sales |
|---|---|---|---|---|---|
| Axon Enterprise AXON | CHIEF EXECUTIVE OFFICER | 16 May 2018 | 8 Sep 2026 | – | 49$786.5M |
| Insight Molecular Diagnostics IMDX | 10% owner | 26 Dec 2024 | 7 Feb 2025 | 5$2.4M | – |
What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.
Median return minus the sector fund, in percentage points; "too few trades" under 5| Open-market trades | After 3 months | After 6 months | After 12 months |
|---|---|---|---|
| After purchases | too few trades3 trades | too few trades3 trades | too few trades3 trades |
| After sales | -21.8 pts32 trades, 19% above the sector | -32.5 pts29 trades, 17% above the sector | +18.0 pts25 trades, 80% above the sector |
For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.
By year
Counted open-market trades, by trade date| Year | Purchases | Bought | Sales | Sold | Net |
|---|---|---|---|---|---|
| 2026 | – | – | 9 | $48.8M | -$48.8M |
| 2025 | 4 | $2.3M | 6 | $39.7M | -$37.5M |
| 2024 | 1 | $192K | 4 | $191.7M | -$191.5M |
| 2023 | – | – | 6 | $222.9M | -$222.9M |
| 2021 | – | – | 12 | $216.2M | -$216.2M |
| 2020 | – | – | 6 | $41.1M | -$41.1M |
| 2019 | – | – | 4 | $5.5M | -$5.5M |
| 2018 | – | – | 2 | $20.4M | -$20.4M |
Every trade
54, newest first; open-market purchases and sales only| Trade date | Company | Side | Shares | Price | Value | Planned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. | Filing |
|---|---|---|---|---|---|---|---|
| 8 Sep 2026 | Axon Enterprise AXON | Sell | 10,000 | $508.99 | $5.1M | 10b5-1 plan | Form 4filed 10 Sep 2026 |
| 7 Aug 2026 | Axon Enterprise AXON | Sell | 70 | $566.62 | $40K | 10b5-1 plan | Form 4filed 11 Aug 2026 |
| 7 Aug 2026 | Axon Enterprise AXON | Sell | 9,930 | $548.77 | $5.4M | 10b5-1 plan | Form 4filed 11 Aug 2026 |
| 7 Jul 2026 | Axon Enterprise AXON | Sell | 10,000 | $643.79 | $6.4M | 10b5-1 plan | Form 4filed 9 Jul 2026 |
| 29 Jun 2026 | Axon Enterprise AXON | Sell | 10,000 | $500.00 | $5.0M | 10b5-1 plan | Form 4filed 30 Jun 2026 |
| 4 Jun 2026 | Axon Enterprise AXON | Sell | 20,000 | $500.00 | $10.0M | 10b5-1 plan | Form 4filed 8 Jun 2026 |
| 9 Mar 2026 | Axon Enterprise AXON | Sell | 10,000 | $560.24 | $5.6M | 10b5-1 plan | Form 4filed 11 Mar 2026 |
| 25 Feb 2026 | Axon Enterprise AXON | Sell | 10,000 | $500.24 | $5.0M | 10b5-1 plan | Form 4filed 26 Feb 2026 |
| 7 Jan 2026 | Axon Enterprise AXON | Sell | 10,000 | $619.01 | $6.2M | 10b5-1 plan | Form 4filed 8 Jan 2026 |
| 8 Dec 2025 | Axon Enterprise AXON | Sell | 10,000 | $551.92 | $5.5M | 10b5-1 plan | Form 4filed 9 Dec 2025 |
| 7 Nov 2025 | Axon Enterprise AXON | Sell | 10,000 | $591.04 | $5.9M | 10b5-1 plan | Form 4filed 12 Nov 2025 |
| 7 Oct 2025 | Axon Enterprise AXON | Sell | 10,000 | $713.74 | $7.1M | 10b5-1 plan | Form 4filed 8 Oct 2025 |
| 8 Sep 2025 | Axon Enterprise AXON | Sell | 10,000 | $743.64 | $7.4M | 10b5-1 plan | Form 4filed 9 Sep 2025 |
| 11 Aug 2025 | Axon Enterprise AXON | Sell | 10,000 | $831.29 | $8.3M | 10b5-1 plan | Form 4filed 12 Aug 2025 |
| 21 Apr 2025 | Axon Enterprise AXON | Sell | 10,000 | $540.99 | $5.4M | 10b5-1 plan | Form 4filed 23 Apr 2025 |
| 7 Feb 2025 | Insight Molecular Diagnostics IMDX | Buy | 1,077,600 | $2.05 | $2.2M | No | Form 4filed 11 Feb 2025 |
| 31 Jan 2025 | Insight Molecular Diagnostics IMDX | Buy | 915 | $2.01 | $2K | No | Form 4filed 4 Feb 2025 |
| 29 Jan 2025 | Insight Molecular Diagnostics IMDX | Buy | 4,198 | $2.01 | $8K | No | Form 4filed 31 Jan 2025 |
| 13 Jan 2025 | Insight Molecular Diagnostics IMDX | Buy | 16,055 | $2.12 | $34K | No | Form 4filed 15 Jan 2025 |
| 26 Dec 2024 | Insight Molecular Diagnostics IMDX | Buy | 90,219 | $2.13 | $192K | No | Form 4filed 27 Dec 2024 |
| 3 Oct 2024 | Axon Enterprise AXON | Sell | 4,767 | $404.14 | $1.9M | 10b5-1 plan | Form 4filed 4 Oct 2024 |
| 30 Sep 2024 | Axon Enterprise AXON | Sellafter exercising options | 165,000 | $402.07 | $66.3M | 10b5-1 plan | Form 4filed 2 Oct 2024 |
| 30 Aug 2024 | Axon Enterprise AXON | Sellafter exercising options | 170,539 | $357.67 | $61.0M | 10b5-1 plan | Form 4filed 4 Sep 2024 |
| 23 Aug 2024 | Axon Enterprise AXON | Sellafter exercising options | 170,300 | $366.73 | $62.5M | 10b5-1 plan | Form 4filed 27 Aug 2024 |
| 3 Apr 2023 | Axon Enterprise AXON | Sellafter exercising options | 2,600 | $224.36 | $583K | 10b5-1 plan | Form 4filed 4 Apr 2023 |
| 29 Mar 2023 | Axon Enterprise AXON | Sellafter exercising options | 222,606 | $220.39 | $49.1M | 10b5-1 plan | Form 4filed 31 Mar 2023 |
| 27 Mar 2023 | Axon Enterprise AXON | Sellafter exercising options | 73,394 | $216.72 | $15.9M | 10b5-1 plan | Form 4filed 28 Mar 2023 |
| 25 Jan 2023 | Axon Enterprise AXON | Sellafter exercising options | 326,399 | $190.35 | $62.1M | Not stated | Form 4filed 27 Jan 2023 |
| 20 Jan 2023 | Axon Enterprise AXON | Sellafter exercising options | 395,818 | $189.38 | $75.0M | Not stated | Form 4filed 24 Jan 2023 |
| 17 Jan 2023 | Axon Enterprise AXON | Sellafter exercising options | 109,032 | $186.12 | $20.3M | Not stated | Form 4filed 19 Jan 2023 |
| 30 Nov 2021 | Axon Enterprise AXON | Sellafter exercising options | 7,881 | $180.30 | $1.4M | Not stated | Form 4filed 2 Dec 2021 |
| 24 Nov 2021 | Axon Enterprise AXON | Sellafter exercising options | 78,474 | $180.10 | $14.1M | Not stated | Form 4filed 29 Nov 2021 |
| 17 Nov 2021 | Axon Enterprise AXON | Sellafter exercising options | 137,267 | $181.61 | $24.9M | Not stated | Form 4filed 19 Nov 2021 |
| 16 Nov 2021 | Axon Enterprise AXON | Sellafter exercising options | 329,952 | $186.25 | $61.5M | Not stated | Form 4filed 17 Nov 2021 |
| 8 Nov 2021 | Axon Enterprise AXON | Sellafter exercising options | 2,216 | $180.59 | $400K | Not stated | Form 4filed 10 Nov 2021 |
| 3 Nov 2021 | Axon Enterprise AXON | Sellafter exercising options | 141,755 | $183.57 | $26.0M | Not stated | Form 4filed 5 Nov 2021 |
| 29 Oct 2021 | Axon Enterprise AXON | Sellafter exercising options | 95,248 | $180.80 | $17.2M | Not stated | Form 4filed 2 Nov 2021 |
| 22 Oct 2021 | Axon Enterprise AXON | Sellafter exercising options | 128,997 | $181.51 | $23.4M | Not stated | Form 4filed 26 Oct 2021 |
| 19 Oct 2021 | Axon Enterprise AXON | Sellafter exercising options | 138,676 | $183.07 | $25.4M | Not stated | Form 4filed 21 Oct 2021 |
| 14 Oct 2021 | Axon Enterprise AXON | Sellafter exercising options | 34,775 | $181.26 | $6.3M | Not stated | Form 4filed 18 Oct 2021 |
| 6 Aug 2021 | Axon Enterprise AXON | Sell | 31,289 | $198.00 | $6.2M | Not stated | Form 4filed 6 Aug 2021 |
| 2 Mar 2021 | Axon Enterprise AXON | Sell | 56,017 | $166.38 | $9.3M | Not stated | Form 4filed 4 Mar 2021 |
| 22 Dec 2020 | Axon Enterprise AXON | Sell | 98,000 | $130.00 | $12.7M | Not stated | Form 4filed 23 Dec 2020 |
| 7 Dec 2020 | Axon Enterprise AXON | Sell | 1,245 | $123.60 | $154K | Not stated | Form 4filed 9 Dec 2020 |
| 27 Nov 2020 | Axon Enterprise AXON | Sell | 98,000 | $125.71 | $12.3M | Not stated | Form 4filed 1 Dec 2020 |
| 9 Oct 2020 | Axon Enterprise AXON | Sell | 98,000 | $98.20 | $9.6M | Not stated | Form 4filed 9 Oct 2020 |
| 3 Mar 2020 | Axon Enterprise AXON | Sell | 29,081 | $80.33 | $2.3M | Not stated | Form 4filed 4 Mar 2020 |
| 22 Jan 2020 | Axon Enterprise AXON | Sell | 50,000 | $79.06 | $4.0M | Not stated | Form 4filed 24 Jan 2020 |
| 17 Dec 2019 | Axon Enterprise AXON | Sell | 4,227 | $71.68 | $303K | Not stated | Form 4filed 18 Dec 2019 |
| 6 Dec 2019 | Axon Enterprise AXON | Sell | 1,245 | $73.30 | $91K | Not stated | Form 4filed 9 Dec 2019 |
| 12 Jun 2019 | Axon Enterprise AXON | Sell | 50,000 | $70.07 | $3.5M | Not stated | Form 4filed 13 Jun 2019 |
| 1 Mar 2019 | Axon Enterprise AXON | Sell | 31,735 | $52.00 | $1.7M | Not stated | Form 4filed 6 Mar 2019 |
| 20 Dec 2018 | Axon Enterprise AXON | Sellafter exercising options | 107,000 | $42.27 | $4.5M | Not stated | Form 4filed 21 Dec 2018 |
| 16 May 2018 | Axon Enterprise AXON | Sellafter exercising options | 300,000 | $53.00 | $15.9M | Not stated | Form 4filed 17 May 2018 |
From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.